Harrer T - Search Results

1

Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells.

Hecht M, Erber S, Harrer T, Klinker H, Roth T, Parsch H, Fiebig N, Fietkau R, Distel LV. Hecht M, et al. Among authors: harrer t. PLoS One. 2015 Jun 18;10(6):e0130277. doi: 10.1371/journal.pone.0130277. eCollection 2015. PLoS One. 2015. PMID: 26086472 Free PMC article.

2

Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS.

Harrer T, Schwab J, Struff WG, Schmitt M, Ficker JH, Rödl W, Parsch H, Kalden JR, Gramatzki M. Harrer T, et al. Infection. 1998 Nov-Dec;26(6):368-74. doi: 10.1007/BF02770838. Infection. 1998. PMID: 9861562

3

Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors.

Walter H, Schmidt B, Korn K, Vandamme AM, Harrer T, Uberla K. Walter H, et al. Among authors: harrer t. J Clin Virol. 1999 Jun;13(1-2):71-80. doi: 10.1016/s1386-6532(99)00010-4. J Clin Virol. 1999. PMID: 10405894

4

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.

Wyen C, Hendra H, Siccardi M, Platten M, Jaeger H, Harrer T, Esser S, Bogner JR, Brockmeyer NH, Bieniek B, Rockstroh J, Hoffmann C, Stoehr A, Michalik C, Dlugay V, Jetter A, Knechten H, Klinker H, Skaletz-Rorowski A, Fätkenheuer G, Egan D, Back DJ, Owen A; German Competence Network for HIV/AIDS Coordinators. Wyen C, et al. Among authors: harrer t. J Antimicrob Chemother. 2011 Sep;66(9):2092-8. doi: 10.1093/jac/dkr272. Epub 2011 Jun 29. J Antimicrob Chemother. 2011. PMID: 21715435 Free article.

5

Cytotoxic effect of efavirenz is selective against cancer cells and associated with the cannabinoid system.

Hecht M, Harrer T, Büttner M, Schwegler M, Erber S, Fietkau R, Distel LV. Hecht M, et al. Among authors: harrer t. AIDS. 2013 Aug 24;27(13):2031-40. doi: 10.1097/QAD.0b013e3283625444. AIDS. 2013. PMID: 23612009

6

Patterns of transmitted HIV drug resistance in Europe vary by risk group.

Frentz D, van de Vijver D, Abecasis A, Albert J, Hamouda O, Jørgensen L, Kücherer C, Struck D, Schmit JC, Vercauteren J, Asjö B, Balotta C, Bergin C, Beshkov D, Camacho R, Clotet B, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis L, Linka KL, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher C, Wensing A; SPREAD Programme. Frentz D, et al. PLoS One. 2014 Apr 10;9(4):e94495. doi: 10.1371/journal.pone.0094495. eCollection 2014. PLoS One. 2014. PMID: 24721998 Free PMC article.

7

Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation.

Hecht M, Harrer T, Körber V, Sarpong EO, Moser F, Fiebig N, Schwegler M, Stürzl M, Fietkau R, Distel LV. Hecht M, et al. Among authors: harrer t. Oncol Lett. 2018 Feb;15(2):1728-1736. doi: 10.3892/ol.2017.7523. Epub 2017 Dec 5. Oncol Lett. 2018. PMID: 29434868 Free PMC article.

8

Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes.

Schmitt M, Harrer E, Goldwich A, Bäuerle M, Graedner I, Kalden JR, Harrer T. Schmitt M, et al. Among authors: harrer e, harrer t. AIDS. 2000 Apr 14;14(6):653-8. doi: 10.1097/00002030-200004140-00004. AIDS. 2000. PMID: 10807188

9

Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction.

Donhauser N, Pritschet K, Helm M, Harrer T, Schuster P, Ries M, Bischof G, Vollmer J, Smola S, Schmidt B; German Competence Network HIV/AIDS. Donhauser N, et al. Among authors: harrer t. PLoS One. 2012;7(3):e33925. doi: 10.1371/journal.pone.0033925. Epub 2012 Mar 21. PLoS One. 2012. PMID: 22470494 Free PMC article.

10

In vitro activation of peripheral mononuclear cells by zinc in HIV-infected patients and healthy controls.

Harrer T, Wolf B, Näger W, Schwarz W, Bergner D, Kalden JR. Harrer T, et al. Clin Exp Immunol. 1992 Aug;89(2):285-9. doi: 10.1111/j.1365-2249.1992.tb06946.x. Clin Exp Immunol. 1992. PMID: 1638772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page